BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

632 related articles for article (PubMed ID: 28029304)

  • 21. Neuropsychological performance in survivors of breast cancer more than 20 years after adjuvant chemotherapy.
    Koppelmans V; Breteler MM; Boogerd W; Seynaeve C; Gundy C; Schagen SB
    J Clin Oncol; 2012 Apr; 30(10):1080-6. PubMed ID: 22370315
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cognitive complaints in cancer: The French version of the Functional Assessment of Cancer Therapy-Cognitive Function (FACT-Cog), normative data from a healthy population.
    Lange M; Heutte N; Morel N; Eustache F; Joly F; Giffard B
    Neuropsychol Rehabil; 2016; 26(3):392-409. PubMed ID: 25947039
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cognitive Function in Patients With Colorectal Cancer Who Do and Do Not Receive Chemotherapy: A Prospective, Longitudinal, Controlled Study.
    Vardy JL; Dhillon HM; Pond GR; Rourke SB; Bekele T; Renton C; Dodd A; Zhang H; Beale P; Clarke S; Tannock IF
    J Clin Oncol; 2015 Dec; 33(34):4085-92. PubMed ID: 26527785
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cognitive complaints after breast cancer treatments: examining the relationship with neuropsychological test performance.
    Ganz PA; Kwan L; Castellon SA; Oppenheim A; Bower JE; Silverman DH; Cole SW; Irwin MR; Ancoli-Israel S; Belin TR
    J Natl Cancer Inst; 2013 Jun; 105(11):791-801. PubMed ID: 23606729
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cognitive limitations associated with tamoxifen and aromatase inhibitors in employed breast cancer survivors.
    Breckenridge LM; Bruns GL; Todd BL; Feuerstein M
    Psychooncology; 2012 Jan; 21(1):43-53. PubMed ID: 20967847
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Assessing brain volume changes in older women with breast cancer receiving adjuvant chemotherapy: a brain magnetic resonance imaging pilot study.
    Chen BT; Sethi SK; Jin T; Patel SK; Ye N; Sun CL; Rockne RC; Haacke EM; Root JC; Saykin AJ; Ahles TA; Holodny AI; Prakash N; Mortimer J; Waisman J; Yuan Y; Somlo G; Li D; Yang R; Tan H; Katheria V; Morrison R; Hurria A
    Breast Cancer Res; 2018 May; 20(1):38. PubMed ID: 29720224
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cognitive function prior to systemic therapy and subsequent well-being in older breast cancer survivors: Longitudinal findings from the Thinking and Living with Cancer Study.
    Kobayashi LC; Cohen HJ; Zhai W; Zhou X; Small BJ; Luta G; Hurria A; Carroll J; Tometich D; McDonald BC; Graham D; Jim HSL; Jacobsen P; Root JC; Saykin AJ; Ahles TA; Mandelblatt J
    Psychooncology; 2020 Jun; 29(6):1051-1059. PubMed ID: 32154959
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Subjective cognitive impairment and brain structural networks in Chinese gynaecological cancer survivors compared with age-matched controls: a cross-sectional study.
    Zeng Y; Cheng ASK; Song T; Sheng X; Zhang Y; Liu X; Chan CCH
    BMC Cancer; 2017 Nov; 17(1):796. PubMed ID: 29179739
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of physical exercise during adjuvant chemotherapy for breast cancer on long-term tested and perceived cognition: results of a pragmatic follow-up study.
    Naaktgeboren WR; Koevoets EW; Stuiver MM; van Harten WH; Aaronson NK; van der Wall E; Velthuis M; Sonke G; Schagen SB; Groen WG; May AM
    Breast Cancer Res Treat; 2024 May; 205(1):75-86. PubMed ID: 38285111
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Symptom burden among older breast cancer survivors: The Thinking and Living With Cancer (TLC) study.
    Mandelblatt JS; Zhai W; Ahn J; Small BJ; Ahles TA; Carroll JE; Denduluri N; Dilawari A; Extermann M; Graham D; Hurria A; Isaacs C; Jacobsen PB; Jim HSL; Luta G; McDonald BC; Patel SK; Root JC; Saykin AJ; Tometich DB; Zhou X; Cohen HJ
    Cancer; 2020 Mar; 126(6):1183-1192. PubMed ID: 31860135
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Self-reported chemotherapy-related cognitive impairment compared with cognitive complaints following menopause.
    Vega JN; Dumas J; Newhouse PA
    Psychooncology; 2018 Sep; 27(9):2198-2205. PubMed ID: 29904964
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Health-related quality of life in early breast cancer.
    Groenvold M
    Dan Med Bull; 2010 Sep; 57(9):B4184. PubMed ID: 20816024
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Potential factors associated with perceived cognitive impairment in breast cancer survivors.
    Myers JS; Wick JA; Klemp J
    Support Care Cancer; 2015 Nov; 23(11):3219-28. PubMed ID: 25832894
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 'Chemobrain' in breast carcinoma?: a prologue.
    Wefel JS; Lenzi R; Theriault R; Buzdar AU; Cruickshank S; Meyers CA
    Cancer; 2004 Aug; 101(3):466-75. PubMed ID: 15274059
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Trajectories of self-reported cognitive function in postmenopausal women during adjuvant systemic therapy for breast cancer.
    Merriman JD; Sereika SM; Brufsky AM; McAuliffe PF; McGuire KP; Myers JS; Phillips ML; Ryan CM; Gentry AL; Jones LD; Bender CM
    Psychooncology; 2017 Jan; 26(1):44-52. PubMed ID: 26486371
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Psychometric properties and measurement equivalence of the English and Chinese versions of the functional assessment of cancer therapy-cognitive in Asian patients with breast cancer.
    Cheung YT; Lim SR; Shwe M; Tan YP; Chan A
    Value Health; 2013; 16(6):1001-13. PubMed ID: 24041350
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cognitive function of older patients receiving adjuvant chemotherapy for breast cancer: a pilot prospective longitudinal study.
    Hurria A; Rosen C; Hudis C; Zuckerman E; Panageas KS; Lachs MS; Witmer M; van Gorp WG; Fornier M; D'Andrea G; Moasser M; Dang C; Van Poznak C; Hurria A; Holland J
    J Am Geriatr Soc; 2006 Jun; 54(6):925-31. PubMed ID: 16776787
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effect of chemotherapy on subjective cognitive function in younger early-stage breast cancer survivors treated with chemotherapy compared to older patients.
    Gregorowitsch ML; Ghedri A; Young-Afat DA; Bijlsma R; Baas IO; van Schaik-van de Mheen C; Agterof MJ; Göker E; Ten Bokkel Huinink D; van den Bongard HJGD; Verkooijen HM;
    Breast Cancer Res Treat; 2019 Jun; 175(2):429-441. PubMed ID: 30746636
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Assessing cognitive function in cancer patients.
    Vardy J; Wong K; Yi QL; Park A; Maruff P; Wagner L; Tannock IF
    Support Care Cancer; 2006 Nov; 14(11):1111-8. PubMed ID: 16538498
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cognitive functioning in breast cancer survivors: a controlled comparison.
    Jim HS; Donovan KA; Small BJ; Andrykowski MA; Munster PN; Jacobsen PB
    Cancer; 2009 Apr; 115(8):1776-83. PubMed ID: 19224550
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 32.